Lysosome

Uses your system voice; voice and rate in settings.

Snapshot

≈ 6 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

A lysosome ( ) is a membrane-bound organelle that is found in all animal cells (except red blood cells), and rarely in plant cells. There are normally hundreds of lysosomes in the cytosol, where they function as the cell's degradation center. Their primary responsibility is for catabolic degradation of proteins, polysaccharides and lipids into their respective building-block molecules: amino acids, monosaccharides, and free fatty acids. The breakdown is done by various enzymes, for example proteases, glycosidases and lipases. With an acidic lumen limited by a single-bilayer lipid membrane, the lysosome holds an environment isolated from the rest of the cell. The lower pH creates optimal conditions for the over 60 different hydrolases inside. Lysosomes receive extracellular particles through endocytosis, and intracellular components through autophagy. They can also fuse with the plasma membrane and secrete their contents, a process called lysosomal exocytosis. After degradation, lysosomal products are transported out of the lysosome through specific membrane proteins or via vesicular membrane trafficking to be recycled or to be utilized for energy. Aside from cellular clearance and secretion, lysosomes mediate biological processes like plasma membrane repair, cell homeostasis, energy metabolism, cell signaling, and the immune response.

A lysosome ( ) is a membrane-bound organelle that is found in all animal cells (except red blood cells), and rarely in plant cells. There are normally hundreds of lysosomes in the cytosol, where they function as the cell's degradation center. Their primary responsibility is for catabolic degradation of proteins, polysaccharides and lipids into their respective building-block molecules: amino acids, monosaccharides, and free fatty acids. The breakdown is done by various enzymes, for example proteases, glycosidases and lipases. With an acidic lumen limited by a single-bilayer lipid membrane, the lysosome holds an environment isolated from the rest of the cell. The lower pH creates optimal conditions for the over 60 different hydrolases inside. Lysosomes receive extracellular particles through endocytosis, and intracellular components through autophagy. They can also fuse with the plasma membrane and secrete their contents, a process called lysosomal exocytosis. After degradation, lysosomal products are transported out of the lysosome through specific membrane proteins or via vesicular membrane trafficking to be recycled or to be utilized for energy. Aside from cellular clearance and secretion, lysosomes mediate biological processes like plasma membrane repair, cell homeostasis, energy metabolism, cell signaling, and the immune response.

Discovery

Christian de Duve, a Belgian scientist at the Laboratory of Physiological Chemistry at the Catholic University of Louvain, is credited with discovering lysosomes in the 1950s. De Duve and his team were studying the distribution of hydrolytic enzymes such as acid phosphatase within cells, using cell fractionation methods to isolate subcellular components. De Duve and his team identified an unknown organelle that was rich in acid phosphatase. This led them to propose the existence of lysosomes as membrane bound organelles containing digestive enzymes capable of breaking down a variety of biological molecules. Using differential centrifugation and enzyme activity assays, the team confirmed the hypothesis and understood that these organelles play a crucial role in intracellular digestion processes, such as phagocytosis and autophagy. The presence of digestive enzymes was further validated using electron microscopy. De Duve's discovery laid the foundation for new research into lysosomal functions and understanding disorders which could lead to undigested materials accumulating in the cell. De Duve was awarded the Nobel Prize in Physiology or Medicine in 1974.

Clinical significance

Lysosomal storage disorders are a group of metabolic disorders that stem from inherited genetic mutations that disrupt normal lysosomal function and homeostasis. Most frequently, the mutations are located in the acidic hydrolases, but can also be found in non-enzymatic lysosomal proteins (soluble and membrane-bound) and non-lysosomal factors controlling lysosomal function. This leads to defective degradation, which induces abnormal accumulations of undigested or partially digested macromolecules within lysosomes. Lysosomal dysfunction also affects transport across the lysosomal membrane, vesicle trafficking, lysosome reformation and autophagy. The stress of accumulated lysosomal substrates can lead to lysosomal membrane permeabilization, allowing hydrolytic enzymes to leak into the cytosol and initiate cell death. This cell loss particularly affects post-mitotic tissues such as the brain, liver, eyes, muscles, and spleen—resulting in the hallmark symptoms of lysosomal storage disorders, including neurodegeneration, cognitive impairment, and motor dysfunction. The age of onset and the specific symptoms in lysosomal storage disorders differ depending on the severity of the mutations, the cell types affected and what substrates accumulate. However, the clinical presentation is typically a neurodegenerative disease at childhood, with more variations presenting themselves in adulthood. In most cases, the central nervous system (CNS) is affected, causing the brain to experience global neurodegeneration, inflammation, activation of the innate immune system and astrogliosis. Several therapeutic strategies have been developed to address lysosomal storage disorders. These include substrate reduction therapy, bone marrow transplantation, gene therapy, and enzyme replacement therapy. Currently, enzyme replacement therapy and substrate reduction are the most widely used. However, despite these advancements, most lysosomal storage disorders still lack effective treatments as the existing ones are limited by poor efficacy and are typically disease specific.

Lysosomotropism

Lysosomotropism refers to the tendency of lipophilic weak bases to accumulate in acidic organelles like lysosomes. While neutral forms of these compounds cross membranes easily, their protonated (charged) forms become trapped inside lysosomes, leading to concentrations up to 1000 times higher than outside the cell. This "acid trapping" or "proton pump" effect can be predicted using mathematical models. Many approved drugs, including haloperidol, levomepromazine, and amantadine, exhibit lysosomotropic behavior. This helps explain their high tissue-to-blood concentration ratios and prolonged tissue retention, though fat solubility also contributes. Some lysosomotropic drugs can interfere with lysosomal enzymes like acid sphingomyelinase. Ambroxol, a mucolytic, promotes lysosomal exocytosis by neutralizing lysosomal pH and releasing stored calcium. This action may underlie its observed benefits in diseases linked to lysosomal dysfunction, including Parkinson's disease and lysosomal storage disorders. 3D structures of proteins associated with lysosome membrane Hide and Seek Foundation For Lysosomal Research Lysosomal Disease Network, a research consortium funded by the NIH through its NCATS/Rare Diseases Clinical Research Network Self-Destructive Behavior in Cells May Hold Key to a Longer Life Animation showing how lysosomes are made, and their function

Text derived from https://en.wikipedia.org/w/index.php?oldid=1378518718 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

5 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.